The Four “I”s of Investigator Motivation – Importance

The perception of importance drives actions in clinical trials. Sponsors must work on creating positive perceptions by demonstrating site value and emphasizing study significance. A compelling story and direct sponsor-site connection elevate a study's importance. To engage sites effectively, consider involving them early, sharing the study's narrative, and treating them as valued partners.

The 4 “I”s of Investigator Motivation – Involvement

Clinical trial sites play a crucial role in research, but are often overlooked. Higher site engagement can boost study performance. Involving sites early, seeking their input, and establishing site relationship teams can improve collaboration and motivation. Treating sites as valuable team members, not subordinates, benefits the entire trial. This approach ultimately leads to better study enrollment.

Be Curious

The clinical trial industry struggles with enrollment due to a lack of curiosity and rushed judgments. The "Be Curious" approach is key to addressing enrollment challenges. Questioning and engaging with diverse sites prior to feasibility assessment is crucial. Understanding and addressing site-specific issues can optimize enrollment and study timelines.

Recruitment Is Not A Priority

Effective clinical trial recruitment is marred by a lack of prioritization. Despite considerable investments, the pivotal steps often slip through the cracks. Fostering a culture that gives due diligence to connecting suitable candidates with study teams is essential.

The 4 I’s of Investigator Motivation – Introduction

A significant factor in recruitment for participants and conduct of clinical trials is Principal Investigator / Site motivation. A motivated investigator can motivate study staff and increase recruitment potential for a trial and decrease site related issues. Conversely, an Investigator or clinical trial site that is not motivated or loses motivation during a trial can result in recruitment slowing or completely halting. It is not uncommon for sites to silently quit studies they were once excited about. This series of articles will examine the 4 I’s of Investigator / site motivation and unpack what can be done to optimize clinical trial conditions.

Create a website or blog at WordPress.com

Up ↑